Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database

Evolving surgical treatment decisions for male breast cancer: an analysis of the National... Background Male breast cancer (MBC) is a rare malignancy, and gender-specific treatment outcomes are currently lacking. The use of a large, multi-national surgical-outcomes database may provide a better understanding of treatment patterns and postoperative morbidity in men who undergo oncological breast surgery. Methods A retrospective cohort analysis was conducted between 2007 and 2016 using the American College of Surgeons National Surgical Quality Improvement Program database (NSQIP), examining MBC treatment patterns and postoperative complication rates. All men undergoing surgery for the treatment of invasive or in situ carcinoma of the breast were identified. Clinical characteristics, demographics, and surgical treatment options most frequently used for this population were described. In addition, the 30-day postoperative complication rates in the surgical treatment of male breast cancer were evaluated. Results A total of 1773 MBC patients with a median age of 65 years (IQR 56–74 years) were included in this analysis. Mean body mass index (BMI) was 29.1 (IQR 25.4–33.8). In this study population, 177 (10.0%) had a diagnosis of in situ breast cancer, while the remaining 1596 (90.0%) had invasive disease. While most men underwent mastectomy, 282 (15.9%) had breast-conserving surgery. There were 74 (4.2%) patients who underwent immediate breast reconstruction. In addition, 118 (6.7%) patients elected http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Breast Cancer Research and Treatment Springer Journals

Evolving surgical treatment decisions for male breast cancer: an analysis of the National Surgical Quality Improvement Program (NSQIP) database

Download PDF
8 pages

Loading next page...
 
/lp/springer_journal/evolving-surgical-treatment-decisions-for-male-breast-cancer-an-0w1599bMMV
Publisher
Springer Journals
Copyright
Copyright © 2018 by Springer Science+Business Media, LLC, part of Springer Nature
Subject
Medicine & Public Health; Oncology
ISSN
0167-6806
eISSN
1573-7217
DOI
10.1007/s10549-018-4830-y
Publisher site
See Article on Publisher Site

Abstract

Background Male breast cancer (MBC) is a rare malignancy, and gender-specific treatment outcomes are currently lacking. The use of a large, multi-national surgical-outcomes database may provide a better understanding of treatment patterns and postoperative morbidity in men who undergo oncological breast surgery. Methods A retrospective cohort analysis was conducted between 2007 and 2016 using the American College of Surgeons National Surgical Quality Improvement Program database (NSQIP), examining MBC treatment patterns and postoperative complication rates. All men undergoing surgery for the treatment of invasive or in situ carcinoma of the breast were identified. Clinical characteristics, demographics, and surgical treatment options most frequently used for this population were described. In addition, the 30-day postoperative complication rates in the surgical treatment of male breast cancer were evaluated. Results A total of 1773 MBC patients with a median age of 65 years (IQR 56–74 years) were included in this analysis. Mean body mass index (BMI) was 29.1 (IQR 25.4–33.8). In this study population, 177 (10.0%) had a diagnosis of in situ breast cancer, while the remaining 1596 (90.0%) had invasive disease. While most men underwent mastectomy, 282 (15.9%) had breast-conserving surgery. There were 74 (4.2%) patients who underwent immediate breast reconstruction. In addition, 118 (6.7%) patients elected

Journal

Breast Cancer Research and Treatment – Springer Journals

Published: May 28, 2018

References

  • Male breast cancer: a population-based comparison with female breast cancer
    Anderson, WF
  • Male breast cancer: a review
    Fentiman, I
  • Breast cancer in men
    Giordano, SH; Buzdar, AU; Hortobagyi, GN
  • Hormone receptor-positive breast cancer has a worse prognosis in male than in female patients
    Li, X
  • Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship
    Ruddy, KJ; Winer, EP
  • Male breast carcinoma: an evaluation of prognostic factors contributing to a poorer outcome
    Joshi, MG
  • Molecular markers in male breast carcinoma
    Rayson, D
  • Male breast cancer in the veterans affairs population: a comparative analysis
    Nahleh, ZA
  • Male and female breast cancer—differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis
    Andre, S
  • Carcinoma of the male breast
    De los Santos, JF; Buchholz, TA
  • Is breast conserving therapy a safe modality for early-stage male breast cancer?
    Zaenger, D
  • Outcomes of partial mastectomy in male breast cancer patients: analysis of SEER, 1983–2009
    Cloyd, JM; Hernandez-Boussard, T; Wapnir, IL
  • Comparative analysis of sentinel lymph node operation in male and female breast cancer patients
    Boughey, JC
  • Sentinel lymph node biopsy is successful and accurate in male breast carcinoma
    Flynn, LW
  • Sentinel lymph node biopsy in male patients with early breast cancer
    Gentilini, O
  • Male breast carcinoma: a review of 229 patients who presented to the Princess Margaret Hospital during 40 years: 1955–1996
    Goss, PE
  • Histologic types and hormone receptors in breast cancer in men: a population-based study in 282 United States men
    Stalsberg, H
  • Male breast cancer: a review of clinical management
    Agrawal, A
  • Male breast disease: clinical, mammographic, and ultrasonographic features
    Gunhan-Bilgen, I
  • Breast conservation for male breast carcinoma
    Golshan, M
  • Management of male breast cancer in the United States: a surveillance, epidemiology and end results analysis
    Fields, EC
  • Carcinoma of the male breast: reconstructive technique
    Caglia, P
  • Carcinoma of the male breast: an underestimated killer
    Benedetto, G; Pierangeli, M; Bertani, A
  • Rectus abdominis myocutaneous flap in reconstruction for advanced male breast cancer: case report
    Igun, GO
  • Male mastectomy: an oncoplastic solution to improve aesthetic appearance
    Schaverien, MV; Scott, JR; Doughty, JC
  • Breast reconstruction in a male with a transverse rectus abdominis flap
    Spear, SL; Bowen, DG
  • Risk of subsequent cancer following breast cancer in men
    Auvinen, A; Curtis, RE; Ron, E
  • Temporal trends in and factors associated with contralateral prophylactic mastectomy among US men with breast cancer
    Jemal, A
  • Thirty-day postoperative morbidity and mortality in elderly women with breast cancer: an analysis of the NSQIP database
    Angarita, FA
  • High body mass index and smoking predict morbidity in breast cancer surgery: a multivariate analysis of 26,988 patients from the national surgical quality improvement program database
    Blacam, C
  • Morbidity and mortality following breast cancer surgery in women: national benchmarks for standards of care
    El-Tamer, MB